neurogesx inc (NGSXE:OTC BB)

Executive Profile*

Background*

Dr. Keith R. Bley, PhD has been Senior Vice President for Product Development at NovaBay Pharmaceuticals, Inc. since March 4, 2013. Dr. Bley joined NovaBay Pharmaceuticals, Inc. in March 4, 2013. Dr. Bley has more than 20 years experience in the pharmaceutical industry with increasingly responsible management positions in research and product development. He served as consultant to various pharmaceutical companies in the Bay Area and assisted these companies with a wide ... range of drug development activities. Dr. Bley served as Senior Vice President, Nonclinical Research & Development of Neurogesx, Inc. since August 2001. Dr. Bley joined NeurogesX in June 2000 as Vice President of Nonclinical Research and Development. From January 1991 to 2000, he held many positions at Roche Bioscience and Syntex (later acquired by Roche). At Roche, he served as Research Manager of the Analgesia Department, where he was involved in the in vitro evaluation of drug candidates for a variety of programs. Dr. Bley has Ph.D. in Cellular and Molecular Physiology from Yale University. He also earned a Masters Degree in Philosophy from Columbia University and has Bachelors in Philosophy (with Honors) from the Catholic University of America in Washington D.C.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NGSXE:US	$0.02 USD	+0.0002

COMPETITOR COMPENSATION